FDA OKs Pancreatic Islet Cell Therapy for Type 1 Diabetes at AshTip Solution.

AshTip NewsLetter |The US Food and Drug Administration (FDA) has approved donislecel (Lantidra, CellTrans Inc), a pancreatic islet cell therapy developed from cadaver donors, for the treatment of people with type 1 diabetes who are unable to achieve target glucose levels owing to severe

Medscape

FDA OKs Pancreatic Islet Cell Therapy for Type 1 Diabetes

FDA OKs Pancreatic Islet Cell Therapy for Type 1 Diabetes

The US Food and Drug Administration (FDA) has approved donislecel (Lantidra, CellTrans Inc), a pancreatic islet cell therapy developed from cadaver donors, for the treatment of people with type 1 diabetes who are unable to achieve target glucose levels owing to severe hypoglycemic episodes.